Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 9 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

8(88.9%)

Early Phase 1

1(11.1%)

9Total

N/A(8)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT04678245Not ApplicableActive Not Recruiting

Network Intervention to Prevent Vaping

Role: collaborator

NCT03208686Not ApplicableCompleted

The Men Are Now United Program

Role: collaborator

NCT03264521Completed

Patient Engagement Via Crowdsourcing

Role: collaborator

NCT04737499Not ApplicableCompleted

Culturally Appropriate Strategies for Chinese Americans With Diabetes (CASCADe)

Role: lead

NCT03243929Not ApplicableCompleted

Translation of District Sun Safe Policies to Schools

Role: lead

NCT03238456Not ApplicableCompleted

Smoking Cessation for Young Adult Pacific Islanders: Motivating Pacifika Against Cigarettes and Tobacco

Role: lead

NCT03175250Not ApplicableCompleted

Translation of Basic Research in Cognitive Science to HIV Risk

Role: lead

NCT03165903Not ApplicableCompleted

Habitual and Neurocognitive Processes in Adolescent Obesity Prevention

Role: lead

NCT00914953Early Phase 1Completed

Oxytocin and Social Behavior Over the Lifespan

Role: lead

NCT01351402Not ApplicableCompleted

Effects of Massage Versus Rest on Hormones

Role: lead

All 10 trials loaded